Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Technology · ·
$7.77
▲ $0.06 (+0.8%)
Market data updated: 09/20 03:48 PM
News analyzed: 09/20/2026
Market Cap
$458.95M
Day Range
$7.45 - $7.80
52-Week Range
$4.78 - $7.97
Beta
—
Next Earnings
28.10.2026
Support
$6.26
Resistance
$7.97
MTLS is a stock from the Technology sector — Software, hardware, chip, and computing-services companies — revenue tied to the pace of innovation and upgrade cycles.
+40.5% (1Y)
🟡 Moderate
Strengths: 10/13 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟢 Bullish
Technical Trend
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Price vs. SMA 50
Price is above the 50-day average
Technical
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.19 (3y annualized return 10.6% / max drawdown 56.8%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
Materialise NV (MTLS) demonstrates a robust overall investor score of 84, underpinned by strong technical performance and positive sentiment, though tempered by notable volatility risk. The technical category scores exceptionally high at 92, reflecting a clear upward momentum: the stock price sits above both its 50-day and 200-day moving averages, while the MACD histogram and RSI (64.4) indicate healthy upward momentum. However, the %K value of 87.8 signals overbought conditions, suggesting potential short-term consolidation. News sentiment is also positive, with multiple mentions of marginal gains in European equities and a feature highlighting MTLS’s high-margin medical business, though minor negative trading fluctuations are noted. The risk category, however, drags the score down to 42 due to a high ATR (3.5% of price) and a volatile KLTAR (0.09) with a maximum 3-year drawdown of 56.8%, indicating significant price swings and potential downside risk. These factors create a mixed but cautiously optimistic outlook, where technical strength and positive narrative are balanced by inherent volatility concerns.
The stock price exceeds both its 50-day and 200-day moving averages, with a positive MACD histogram and RSI of 64.4 indicating strong upward momentum, though %K at 87.8 suggests overbought conditions.
This technical alignment typically signals bullish momentum, but overbought conditions may prompt near-term pullbacks.
Positive sentiment dominates, with multiple references to marginal gains in European equities and a feature emphasizing MTLS’s high-margin medical sector, though minor negative trading fluctuations are present.
Positive narrative strengthens investor confidence, while minor negative trading activity introduces minor uncertainty.
The ATR stands at 3.5% of the stock price, and the KLTAR (0.09) reveals a 56.8% maximum 3-year drawdown, indicating high volatility and potential for significant price swings.
Such volatility can amplify both gains and losses, posing a material risk to investors seeking stability.
StockIQ conclusion
Materialise NV (MTLS) presents a compelling yet volatile profile, with strong technical indicators and positive news sentiment offset by inherent volatility risks. The stock’s ability to sustain momentum depends on managing high volatility and potential overbought corrections, while its high-margin medical business remains a key growth driver. Investors should monitor volatility metrics and sector-specific developments to assess long-term viability.
Written automatically from the computed data shown on this page only — not investment advice.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
82
Today
—
30D
—
90D
—
1Y
🕰️ Signal Timeline
What StockIQ actually saw for this stock, and what happened after each signal — real data, not a forecast.
today · $7.77
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
today · $7.77
Evidence: 10 bullish / 0 bearish technical signals agreeing
What happened after
Still awaiting outcome
1d ago · $7.77
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
1d ago · $7.77
Evidence: 10 bullish / 0 bearish technical signals agreeing
What happened after
Still awaiting outcome
2d ago · $7.59
Evidence: -3.7pp vs. sector average today
What happened after
Still awaiting outcome
2d ago · $7.71
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
2d ago · $7.71
Evidence: 10 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
3d ago · $7.70
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
3d ago · $7.70
Evidence: 10 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
4d ago · $7.66
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
4d ago · $7.66
Evidence: 10 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
5d ago · $7.63
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
5d ago · $7.63
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
5d ago · $7.65
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
5d ago · $7.65
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
6d ago · $7.64
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
6d ago · $7.64
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
7d ago · $7.64
Evidence: Euphoria score crossed 55 (now 57)
What happened after
Still awaiting outcome
7d ago · $7.64
Evidence: המניה במגמת עלייה ברורה ללא טווח מסחר מוגדר בטווח הזמן שנבדק.
What happened after
Still awaiting outcome
7d ago · $7.64
Evidence: 11 bullish / 1 bearish technical signals agreeing
What happened after
Still awaiting outcome
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🕰️ StockIQ Time Machine
What did StockIQ know — and when? Pick a date from the real accumulated history.
As of August 29, 2026
Then
75
$7.02
Now
82
$7.77
What happened since
Signals detected by this date
No signals detected by this date
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
No data available
Quality
No data available
Value
No data available
Momentum
91
Risk
42
Sentiment
80
Fundamental
No data available
Institutional
No data available
Stocks with a similar DNA right now
Not enough comparably-scored stocks yet to show similar matches.
🕵️ What the Detective found on MTLS
Detective Score 70/100 · 2 signals convergingOverall, the signals found here lean positive.
🧠 What the Detective thinks
2 signals are currently converging on MTLS at once — see each one broken down below, in plain language, with its own positive/negative read.
What this means now: Several different technical indicators are currently agreeing on the same direction at once — that's unusual; most days they contradict each other.
Why it matters: When several technical indicators agree at once, that's usually more reliable than any single indicator alone.
What this means now: The price has formed a distinct technical structure (a trading range, shakeout, or breakout) that the Wyckoff method treats as a key moment where big money is building or unwinding a position.
Why it matters: May provide an additional indication of trading structure, but is not proof of future direction.
📊 Historically, this signal type
This is not a prediction and not investment advice — just a plain-language read of real, already-computed signals. Full details: Stock Detective →
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **Materialise NV** has focused on its strong financial performance and strategic initiatives. The company reported a **9.6% surge in medical revenue** in Q2 2026, prompting management to raise full-year profit guidance. Additionally, Materialise announced the **resumption of its stock buyback plan** on August 31, signaling confidence in its financial health. Analysts highlight its **high-margin medical business** as a key growth driver, though software-related risks are noted. Market reactions were mixed but generally positive.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Materialise NV. News trend score: 80. Reason: 11 of the last 20 articles are positive, versus 6 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
45
🎯 Conviction (vs. Emotion)
50
Psychology
50
Fundamentals
—
Technical
91
Valuation
—
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+16%
Market Narrative
68
Fundamental Reality
50
Narrative Gap
+18
🧠 StockIQ Psychologist
The market behavior suggests traders are fixating on a near-term resistance level (1.3% away), consistent with anchoring bias. Positive momentum, elevated volume, and euphoric sentiment (euphoria score 53) indicate excitement, but the dominant anchoring (74) implies hesitation near a psychological barrier. The narrative gap (28) hints at a disconnect between optimistic expectations and current fundamentals. The key question: will traders break resistance or retreat if momentum stalls?
Updated: 09/09/2026, 01:56 PM
What could change this?
🧠 Market Brain events driving this
📈 18D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Jesse Livermore — 78/100
🔴 Weakest match
Samuel Armstrong Nelson — 11/100
🗣️ Why do they disagree?
This stock presents a stark contrast between technical and fundamental investors. Jesse Livermore’s high score suggests the stock exhibits the price action he favored—strong momentum or trend confirmation—while the majority of value-oriented methodologies like Graham, Fisher, and Lynch hit neutral due to insufficient fundamental or valuation data. Meanwhile, risk-averse thinkers like Gerald Loeb, Howard Marks, and Charles Mackay flag red flags, with Loeb and Marks warning of excessive risk or valuation mispricing, while Mackay and Nelson see it as a speculative bubble or overbought cycle. The divide underscores whether the stock’s appeal lies in its price movement (Livermore) or whether its fundamentals are too murky or volatile (Marks, Nelson) to justify a disciplined bet.
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟢 78
Positive trend — the price action Livermore looked for
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Not enough balance-sheet/valuation data for a real Graham read
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 50
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Peter Lynch
One Up on Wall Street (1989)
🟡 50
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 50
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 50
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 50
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Jack Schwager
Market Wizards (1989)
🟡 49
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 40
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🔴 33
Pattern consistent with a crowd delusion Mackay would flag
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 32
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 27
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🔴 24
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🔴 15
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 11
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Based on the last 281 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (10 bullish · 0 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Sentiment based on basic keywords (not AI) — 11 positive, 3 neutral, 6 negative out of the last 20 articles.
Yahoo · 10.9.2026
MT Newswires · 10.9.2026
Yahoo · 4.9.2026
MT Newswires · 4.9.2026
SeekingAlpha · 31.8.2026
Yahoo · 31.8.2026
MT Newswires · 31.8.2026
Yahoo · 31.8.2026
Motley Fool · 31.8.2026
Benzinga · 28.8.2026
Yahoo · 28.8.2026
MT Newswires · 28.8.2026
SeekingAlpha · 28.8.2026
Yahoo · 27.8.2026
GuruFocus.com · 27.8.2026
Yahoo · 27.8.2026
MT Newswires · 27.8.2026
Yahoo · 27.8.2026
MarketBeat · 27.8.2026
SeekingAlpha · 27.8.2026
StockIQ doesn't currently have enough real data to compute a reliable score for Materialise NV (MTLS) — only 3 of 7 categories are available right now. Rather than show a misleading number, this page shows which data is missing instead.
StockIQ doesn't give buy/sell recommendations — and for MTLS specifically, there currently isn't enough real data (only 3 of 7 categories available) to state even a factual score reliably. Check back once more data is available.
MTLS's technical score is 91/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Price is above the 50-day average; Price is above the 200-day average; MACD histogram is positive — rising momentum.
Based on the real signals StockIQ computed: Calmar: 0.19 (3y annualized return 10.6% / max drawdown 56.8%).
StockIQ has no recorded dividend payment history for MTLS.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 0 filings.
No recent insider transaction filings found for this stock.
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
312,895 shares short as of 2026-08-31 · vs. 401,338 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
49.5% of trading volume this week was short selling, vs. 43.3% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology